These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 18951306)

  • 1. [Effect of VEGF165 and the VEGF aptamer pegaptanib (Macugen) on the protein composition of tight junctions in microvascular endothelial cells of the retina].
    Deissler HL; Lang GE
    Klin Monbl Augenheilkd; 2008 Oct; 225(10):863-7. PubMed ID: 18951306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VEGF-induced effects on proliferation, migration and tight junctions are restored by ranibizumab (Lucentis) in microvascular retinal endothelial cells.
    Deissler H; Deissler H; Lang S; Lang GE
    Br J Ophthalmol; 2008 Jun; 92(6):839-43. PubMed ID: 18511543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VEGF but not PlGF disturbs the barrier of retinal endothelial cells.
    Deissler HL; Deissler H; Lang GK; Lang GE
    Exp Eye Res; 2013 Oct; 115():162-71. PubMed ID: 23891860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of vascular endothelial growth factor (VEGF) is sufficient to completely restore barrier malfunction induced by growth factors in microvascular retinal endothelial cells.
    Deissler HL; Deissler H; Lang GE
    Br J Ophthalmol; 2011 Aug; 95(8):1151-6. PubMed ID: 21273213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Capacity of aflibercept to counteract VEGF-stimulated abnormal behavior of retinal microvascular endothelial cells.
    Deissler HL; Lang GK; Lang GE
    Exp Eye Res; 2014 May; 122():20-31. PubMed ID: 24631334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [In vitro studies on the mechanism of action of VEGF and its inhibitors].
    Deissler HL; Lang GE
    Klin Monbl Augenheilkd; 2008 Jul; 225(7):623-8. PubMed ID: 18642204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blocking of VEGF-A is not sufficient to completely revert its long-term effects on the barrier formed by retinal endothelial cells.
    Deissler HL; Rehak M; Busch C; Wolf A
    Exp Eye Res; 2022 Mar; 216():108945. PubMed ID: 35038456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VEGF receptor 2 inhibitor nintedanib completely reverts VEGF-A
    Deissler HL; Stutzer JN; Lang GK; Grisanti S; Lang GE; Ranjbar M
    Exp Eye Res; 2020 May; 194():108004. PubMed ID: 32184103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decursin inhibits VEGF-mediated inner blood-retinal barrier breakdown by suppression of VEGFR-2 activation.
    Kim JH; Kim JH; Lee YM; Ahn EM; Kim KW; Yu YS
    J Cereb Blood Flow Metab; 2009 Sep; 29(9):1559-67. PubMed ID: 19536074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered expression of genes related to blood-retina barrier disruption in streptozotocin-induced diabetes.
    Klaassen I; Hughes JM; Vogels IM; Schalkwijk CG; Van Noorden CJ; Schlingemann RO
    Exp Eye Res; 2009 Jun; 89(1):4-15. PubMed ID: 19284967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transport and fate of aflibercept in VEGF-A
    Deissler HL; Sommer K; Lang GK; Lang GE
    Exp Eye Res; 2020 Sep; 198():108156. PubMed ID: 32712182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor increases GEnC permeability by affecting the distributions of occludin, ZO-1 and tight juction assembly.
    Zhang L; Liu H; Peng YM; Dai YY; Liu FY
    Eur Rev Med Pharmacol Sci; 2015; 19(14):2621-7. PubMed ID: 26221892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Actions of bevacizumab and ranibizumab on microvascular retinal endothelial cells: similarities and differences.
    Deissler HL; Deissler H; Lang GE
    Br J Ophthalmol; 2012 Jul; 96(7):1023-8. PubMed ID: 22539748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of protein kinase C is not sufficient to prevent or reverse effects of VEGF165 on claudin-1 and permeability in microvascular retinal endothelial cells.
    Deissler HL; Deissler H; Lang GE
    Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):535-42. PubMed ID: 19643968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endostatin modulates VEGF-mediated barrier dysfunction in the retinal microvascular endothelium.
    Brankin B; Campbell M; Canning P; Gardiner TA; Stitt AW
    Exp Eye Res; 2005 Jul; 81(1):22-31. PubMed ID: 15978251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Single Routes of Intracellular Signaling is Not Sufficient to Neutralize the Biphasic Disturbance of a Retinal Endothelial Cell Barrier Induced by VEGF-A165.
    Deissler HL; Lang GK; Lang GE
    Cell Physiol Biochem; 2017; 42(4):1493-1513. PubMed ID: 28719888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. VEGF increases BMEC monolayer permeability by affecting occludin expression and tight junction assembly.
    Wang W; Dentler WL; Borchardt RT
    Am J Physiol Heart Circ Physiol; 2001 Jan; 280(1):H434-40. PubMed ID: 11123261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does VEGF secreted by leukemic cells increase the permeability of blood-brain barrier by disrupting tight-junction proteins in central nervous system leukemia?
    Feng S; Huang Y; Chen Z
    Med Hypotheses; 2011 May; 76(5):618-21. PubMed ID: 21398042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiopoietin modulation of vascular endothelial growth factor: Effects on retinal endothelial cell permeability.
    Peters S; Cree IA; Alexander R; Turowski P; Ockrim Z; Patel J; Boyd SR; Joussen AM; Ziemssen F; Hykin PG; Moss SE
    Cytokine; 2007 Nov; 40(2):144-50. PubMed ID: 17959386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of VEGF-A is sufficient to abrogate the disturbing effects of VEGF-B together with VEGF-A on retinal endothelial cells.
    Deissler HL; Lang GK; Lang GE
    Graefes Arch Clin Exp Ophthalmol; 2015 Jun; 253(6):885-94. PubMed ID: 25663437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.